AU5779196A - Novel 2-amino-3-phenylpropionic acid derivatives - Google Patents
Novel 2-amino-3-phenylpropionic acid derivativesInfo
- Publication number
- AU5779196A AU5779196A AU57791/96A AU5779196A AU5779196A AU 5779196 A AU5779196 A AU 5779196A AU 57791/96 A AU57791/96 A AU 57791/96A AU 5779196 A AU5779196 A AU 5779196A AU 5779196 A AU5779196 A AU 5779196A
- Authority
- AU
- Australia
- Prior art keywords
- amino
- novel
- acid derivatives
- phenylpropionic acid
- phenylpropionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7-133460 | 1995-05-31 | ||
| JP7133460A JPH08325263A (ja) | 1995-05-31 | 1995-05-31 | 新規2−アミノ−3−フェニルプロピオン酸誘導体 |
| PCT/JP1996/001380 WO1996038415A1 (fr) | 1995-05-31 | 1996-05-24 | Nouveaux derives de l'acide 2-amino-3-phenylpropionique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5779196A true AU5779196A (en) | 1996-12-18 |
Family
ID=15105306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU57791/96A Abandoned AU5779196A (en) | 1995-05-31 | 1996-05-24 | Novel 2-amino-3-phenylpropionic acid derivatives |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPH08325263A (fr) |
| AU (1) | AU5779196A (fr) |
| WO (1) | WO1996038415A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU717699B2 (en) * | 1996-02-28 | 2000-03-30 | Glaxo Group Limited | Chemical compounds |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2259487A1 (fr) | 1996-07-01 | 1998-01-08 | Margaret Mary Faul | Composes hypoglycemiants et hypolipidemiants |
| CN1233241A (zh) * | 1996-08-19 | 1999-10-27 | 日本烟草产业株式会社 | 丙酸衍生物及其用途 |
| US6353023B1 (en) | 1997-08-28 | 2002-03-05 | Pharmacia & Upjohn Company | Inhibitors of protein tyrosine phosphatase |
| US6410585B1 (en) * | 1997-08-28 | 2002-06-25 | Scott D. Larsen | Inhibitors of protein tyrosine phosphatase |
| AU738134B2 (en) * | 1997-10-02 | 2001-09-06 | Sankyo Company Limited | Amidocarboxylic acid derivatives |
| GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| EG24179A (en) * | 1999-09-07 | 2008-09-28 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| TWI260321B (en) | 1999-09-22 | 2006-08-21 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| GB0002667D0 (en) * | 2000-02-04 | 2000-03-29 | Glaxo Group Ltd | medicamesnts |
| WO2003059895A1 (fr) * | 2002-01-17 | 2003-07-24 | Toaeiyo Ltd. | Derives d'acide halogenobenzylaminopropionique |
| US7345068B2 (en) | 2002-02-07 | 2008-03-18 | Hitoshi Endou | Aromatic amino acid derivatives and medicinal compositions |
| US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
| WO2004004665A2 (fr) | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Derives heterocycliques substitues utilises en tant qu'agents contre le diabete et contre l'obesite, et methode associee |
| CN1738807A (zh) * | 2002-11-15 | 2006-02-22 | 卡地拉健康护理有限公司 | 取代的芳烷基衍生物 |
| ES2219180B1 (es) * | 2003-05-09 | 2006-03-01 | Medichem, S.A. | Compuesto intermedio util para la preparacion de pioglitazona. |
| EP1622898A1 (fr) * | 2003-05-13 | 2006-02-08 | Synthon B.V. | Procedes de fabrication de derives de thiazolidinedione et composes associes |
| CN100436430C (zh) * | 2004-05-24 | 2008-11-26 | 北京摩力克科技有限公司 | 作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物 |
| JPWO2008081537A1 (ja) * | 2006-12-28 | 2010-04-30 | 株式会社ヒューマンセルシステムズ | Lat1阻害活性を有する芳香族アミノ酸誘導体、それを含有するlat1阻害活性剤及びその製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03503650A (ja) * | 1988-04-05 | 1991-08-15 | アボツト・ラボラトリーズ | Cckアンタゴニストとしてのトリプトファン誘導体 |
| IE902295A1 (en) * | 1989-07-07 | 1991-01-16 | Abbott Lab | Amino acid analog cck antagonists |
| GB9311661D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
| DE69424846T2 (de) * | 1993-11-16 | 2000-11-16 | Novartis Ag, Basel | Zyklische Aminosäure-Derivate mit ACE und NEP inhibierender Aktivität |
| SI0656348T1 (en) * | 1993-12-03 | 2000-08-31 | F. Hoffmann-La Roche Ag | Aceric acid derivatives as medicaments |
-
1995
- 1995-05-31 JP JP7133460A patent/JPH08325263A/ja active Pending
-
1996
- 1996-05-24 AU AU57791/96A patent/AU5779196A/en not_active Abandoned
- 1996-05-24 WO PCT/JP1996/001380 patent/WO1996038415A1/fr active Application Filing
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU717699B2 (en) * | 1996-02-28 | 2000-03-30 | Glaxo Group Limited | Chemical compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996038415A1 (fr) | 1996-12-05 |
| JPH08325263A (ja) | 1996-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4665596A (en) | Pyrazolylbenzoyl derivatives | |
| GB9504065D0 (en) | Poly-pyrrolecarboxamidonaphthalenic acid derivatives | |
| AU7626596A (en) | Oxymethoxy-3-aryl-pyrone derivatives | |
| AU4086296A (en) | Indolepiperidine derivatives | |
| AU667757B2 (en) | Quinolone- and naphthyridonecarboxylic acid derivatives | |
| AU1195897A (en) | Heteroarylcarboxamide derivatives | |
| AU7053296A (en) | Purin-6-one derivatives | |
| AU5779196A (en) | Novel 2-amino-3-phenylpropionic acid derivatives | |
| AU4875296A (en) | Isoxazolyl-benzoyl derivatives | |
| AU5763596A (en) | 2-ureido-benzamide derivatives | |
| AU7930394A (en) | Pyrimidinyl-glutamic acid derivatives | |
| AU6191796A (en) | Sulfonyl- or sulfinylbenzoylguanidine derivatives | |
| AU7084796A (en) | Diarylalkenylamine derivatives | |
| AU4547796A (en) | Hexahydropyrazinoquinoline derivatives | |
| AU5052296A (en) | 4-indolylpiperazinyl derivatives | |
| AU4547896A (en) | 4-oxo-2-butenoic acid derivatives | |
| AU2629295A (en) | Trifluoromethylquinolinecarboxylic acid derivative | |
| AU4211296A (en) | 4-aminobenzoylguanidine derivatives | |
| AU6929696A (en) | Pyrazol-4-ylbenzoyl derivatives | |
| AU5758894A (en) | Acyloxyhexanoic acid derivatives | |
| AU4547396A (en) | Thioquinoline derivatives | |
| AU6214896A (en) | Alkenyl-benzoylguanidine derivatives | |
| AU6737996A (en) | Boronic acid derivatives | |
| AU5635496A (en) | Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid | |
| AU4220096A (en) | 4-mercaptobenzoylguanidine derivatives |